Klingman & Associates’s GE HealthCare GEHC Stock Holding History

Klingman & Associates’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$284K	Buy	3,985 +253	+7%	+$20K	0.01%	270
2025 Q4	$306K	Buy	3,732 +98	+3%	+$7.64K	0.01%	252
2025 Q3	$273K	Buy	3,634 +139	+4%	+$10.4K	0.01%	270
2025 Q2	$259K	Sell	3,495 -1,716	-33%	-$119K	0.01%	269
2025 Q1	$421K	Buy	5,211 +23	+0.4%	+$1.98K	0.03%	177
2024 Q4	$406K	Sell	5,188 -2,056	-28%	-$175K	0.02%	175
2024 Q3	$680K	Buy	7,244 +3,788	+110%	+$318K	0.04%	133
2024 Q2	$269K	Buy	3,456 +559	+19%	+$45.6K	0.02%	206
2024 Q1	$263K	Buy	2,897 +38	+1%	+$3.16K	0.02%	204
2023 Q4	$221K	Buy	+2,859	New	+$200K	0.02%	216
2023 Q3	–	Sell	-2,889	Closed	-$235K	–	224
2023 Q2	$235K	Buy	2,889 +27	+0.9%	+$2.15K	0.02%	194
2023 Q1	$235K	Buy	+2,862	New	+$204K	0.02%	180

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Klingman & Associates's GEHC Position: Q1 2026 in Review

Klingman & Associates increased its GE HealthCare (GEHC) stake by 6.8% in Q1 2026, buying an estimated $20K and bringing the position to 3,985 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #270.

Klingman & Associates first reported a position in GEHC in Q1 2023 and has held it in 12 quarters since. The position peaked at $680K in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Klingman & Associates held 3,985 shares of GE HealthCare worth $284K as of Q1 2026.
Klingman & Associates bought 253 GE HealthCare shares in Q1 2026, an estimated $20K.
GE HealthCare made up 0.01% of Klingman & Associates's portfolio in Q1 2026, its #270 holding.
Klingman & Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 12 quarters since.
Klingman & Associates's GE HealthCare position peaked at $680K in Q3 2024.
1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.